Medy-Tox Inc (086900) — Cash Flow-to-Debt Ratio
Medy-Tox Inc (086900) has a Cash Flow-to-Debt Ratio of 0.16x as of September 2025, meaning its operating cash flow of ₩19.03 Billion could theoretically repay 0% of its total liabilities (₩119.26 Billion) in one year. See Medy-Tox Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Medy-Tox Inc Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Medy-Tox Inc across 12 annual periods. Also explore Medy-Tox Inc equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Medy-Tox Inc (2013–2024)
Year-by-year debt coverage analysis for Medy-Tox Inc. For market capitalisation and broader financial context, see market value of Medy-Tox Inc.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.26x | ₩36.89 Billion | ₩144.38 Billion | ▲ +159.2% |
| 2023 | 0.10x | ₩13.52 Billion | ₩137.14 Billion | ▼ -36.7% |
| 2022 | 0.16x | ₩26.20 Billion | ₩168.24 Billion | ▲ +39.0% |
| 2021 | 0.11x | ₩19.97 Billion | ₩178.22 Billion | ▼ -9.2% |
| 2020 | 0.12x | ₩27.93 Billion | ₩226.37 Billion | ▼ -40.6% |
| 2019 | 0.21x | ₩33.70 Billion | ₩162.38 Billion | ▼ -46.3% |
| 2018 | 0.39x | ₩55.07 Billion | ₩142.43 Billion | ▲ +29.4% |
| 2017 | 0.30x | ₩56.55 Billion | ₩189.29 Billion | ▼ -2.6% |
| 2016 | 0.31x | ₩54.10 Billion | ₩176.35 Billion | ▲ +23.5% |
| 2015 | 0.25x | ₩22.37 Billion | ₩90.07 Billion | ▼ -79.5% |
| 2014 | 1.21x | ₩105.38 Billion | ₩86.92 Billion | ▲ +36.8% |
| 2013 | 0.89x | ₩16.60 Billion | ₩18.73 Billion | — |